0OD6 Stock Chart & Stats
€8.94
€0.00(0.00%)
At close: 4:00 PM EST
€8.94
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€8.94 - €11.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.21B
Enterprise Value€4.89K
Total Cash (Recent Filing)€302.20M
Total Debt (Recent Filing)€4.03B
Price to Earnings (P/E)―
Beta-0.19
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.52
Shares Outstanding110,389,690
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio5.92
Price to Book (P/B)1.05
Price to Sales (P/S)0.22
P/FCF Ratio3.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Gross MarginsSustained gross margins near 78%-80% indicate that the healthcare services model retains strong unit economics. This provides a durable buffer against cost pressure and supports operating profitability if treatment volumes and reimbursement conditions stabilize.
Positive Cash GenerationConsistently positive operating and free cash flow demonstrates that the facilities generate cash despite reported net losses. This supports ongoing operations and gives management some capacity to fund investment or gradually reduce debt, although coverage remains limited.
Positive Operating ProfitabilityPositive operating profitability and the multi-year revenue expansion preceding the latest period suggest the underlying hospital platform has meaningful demand and operating capability. These strengths could support recovery if the recent disruption in revenue is contained.
Bears Say
Sharp Revenue ContractionA 32.8% latest-period revenue decline materially weakens the growth profile and raises concerns about patient volumes, case mix, or reimbursement-related pressure. If persistent, lower scale would reduce operating leverage and make debt servicing more difficult.
Sustained Net LossesSeveral consecutive years of net losses indicate that strong gross margins are not translating into shareholder profitability. Persistent losses can erode equity, restrict reinvestment, and increase dependence on operating recovery or external financing.
High LeverageHigh debt relative to declining equity leaves the company exposed to earnings volatility and refinancing conditions. Although cash flow is positive, debt coverage is modest at roughly 0.34x-0.43x, limiting flexibility until profitability improves or leverage falls.
Ramsay Generale de Sante News
0OD6 FAQ
What was Ramsay Generale de Sante SA’s price range in the past 12 months?
Ramsay Generale de Sante SA lowest share price was €8.94 and its highest was €11.40 in the past 12 months.
What is Ramsay Generale de Sante SA’s market cap?
Ramsay Generale de Sante SA’s market cap is €1.21B.
When is Ramsay Generale de Sante SA’s upcoming earnings report date?
Ramsay Generale de Sante SA’s upcoming earnings report date is Nov 05, 2026 which is in 64 days.
How were Ramsay Generale de Sante SA’s earnings last quarter?
Ramsay Generale de Sante SA released its earnings results on Aug 26, 2026. The company reported -€0.124 earnings per share for the quarter.
Is Ramsay Generale de Sante SA overvalued?
According to Wall Street analysts Ramsay Generale de Sante SA’s price is currently Overvalued.
Does Ramsay Generale de Sante SA pay dividends?
Ramsay Generale de Sante SA does not currently pay dividends.
What is Ramsay Generale de Sante SA’s EPS estimate?
Ramsay Generale de Sante SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ramsay Generale de Sante SA have?
Ramsay Generale de Sante SA has 110,389,690 shares outstanding.
What happened to Ramsay Generale de Sante SA’s price movement after its last earnings report?
Ramsay Generale de Sante SA reported an EPS of -€0.124 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ramsay Generale de Sante SA?
Currently, no hedge funds are holding shares in GB:0OD6
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ramsay Generale de Sante SA
Ramsay Générale de Santé S.A., headquartered in Paris, France, manages a network of hospitals across the nation. These facilities provide a wide spectrum of healthcare services, including specialized care in anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity management, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology. Furthermore, they conduct various surgical procedures such as thoracic, vascular, and endovascular interventions. Founded in 1987, the company adopted its current name in December 2015, having previously been known as Générale de Santé SA. Ramsay Générale de Santé S.A. functions as a subsidiary of Ramsay Health Care Limited.